Alan S. Brown, M.D.
Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital Clinical Associate Professor, Loyola University Medical Center
Estimated Time of Talk
45 min webcast = 0.75 credits
15 min Q&A = 0.25 credits
Total = 1.0 credits
This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia.
This presentation was created and presented before the results of the REDUCE-IT trial were released.
1. Understand the effect of hypertriglyceridemia on CHD risk.
2. Review treatment strategies to reduce risk of pancreatitis and CHD events.
3. Review appropriate therapies for patients with elevated triglycerides.
Speaker – Amgen, Regeneron, Sanofi, Advisory Board- Amarin, Kastle, Kowa, Pfizer, Sanofi